Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M, Dzubak P, Srovnal J, Radova L, Burianova R, Konecny P, Salkova S, Novak Z, Pospisilova D, Stary J, Blazek B, Hak J, Votava T, Timr P, Kaiserova E, Bubanska E, Mihal V, Hajduch M. Spenerova M, et al. Among authors: timr p. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Sep;158(3):422-7. doi: 10.5507/bp.2012.059. Epub 2012 Oct 31. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014. PMID: 23128824 Free article.
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
Starý J, Gajdos P, Blazek B, Ptoszková H, Mihál V, Pospísilová D, Hrstková H, Dembická D, Kopecná L, Slavík Z, Hak J, Procházková D, Zahálka F, Cerná Z, Jabali Y, Timr P, Vávra V, Mydlil J, Hrusák O, Trka J. Starý J, et al. Among authors: timr p. Cas Lek Cesk. 2003;142(7):404-9. Cas Lek Cesk. 2003. PMID: 14515443 Clinical Trial. Czech.
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
Zdráhalová K, Štěrba J, Domanský J, Blažek B, Ptoszková H, Mihál V, Novák Z, Hak J, Procházková D, Černá Z, Timr P, Jabali Y, Sedláček P, Smíšek P, Zemanová Z, Jarošová M, Houdková A, Mejstříková E, Hrušák O, Zuna J, Janotová I, Trka J, Starý J. Zdráhalová K, et al. Among authors: timr p. Cas Lek Cesk. 2015;154(2):79-89. Cas Lek Cesk. 2015. PMID: 25994910 Clinical Trial. Czech.